Savara Inc

XNAS:SVRA   4:00:00 PM EDT
4.27
+0.12 (+2.89%)
: $4.27 0.00 (-0.01%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Savara Inc Stock, XNAS:SVRA

One Summit Square, 1717 Langhorne Newtown Road, Langhorne, Pennsylvania 19047
United States of America
Phone: +1.512.614.1848
Number of Employees: 37
http://www.savarapharma.com

Description

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.